Acta Oncologica

ISSN 0284-186x · Taylor & Francis · United Kingdom · active 1964–2026

Metrics

Best Scimago quartile (2025)
Q1
Cites per paper (2y)
2.7
SJR
0.952
h-index
151

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.

Data as of 1 November 2026 (venue index build).

Scimago Journal Rank 2025

In the Scimago Journal Rank 2025 edition, Acta Oncologica is Q1 in 2 of its 4 subject categories and Q2 in the other 2. Its best category quartile is Q1.

Scimago 2025 quartile and rank of Acta Oncologica in each subject category
Subject categoryQuartileRank in category
Radiology, Nuclear Medicine and ImagingQ1#67 of 360
Medicine (miscellaneous)Q1#562 of 2,517
HematologyQ2#43 of 151
OncologyQ2#154 of 426
Cites per document (2 years, Scopus)
2.31
Documents indexed in 2025 (Scopus)
208

The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).

Acta Oncologica is Q1 in 2 of its 4 Scimago subject categories (2025 edition; best category Radiology, Nuclear Medicine and Imaging: Q1, #67 of 360), with SJR 0.952 (Scimago) and an h-index of 151 (OpenAlex). Listed in DOAJ, Scopus, Web of Science, PubMed.

Is this the right journal for your paper?

The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.

Try the Journal Finder →

Responding time

Submission to publication
~9 wk
DOAJ self-reported

Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.

Indexing & access

Indexed in
DOAJScopusWeb of SciencePubMed
Access status:
gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Official journal site →

Scope

advancedradiotherapytechniquesradiationcancersurvivorshipcareoncologybreasttreatmenttherapydosimetry

Frequently asked

Is Acta Oncologica a predatory journal?

Our screening does not flag Acta Oncologica. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.

Is Acta Oncologica indexed in Scopus or Web of Science?

Per our venue index, Acta Oncologica appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is the impact factor of Acta Oncologica?

Papers in Acta Oncologica are cited about 2.7 times each within two years of publication, and Scimago places it in Q1, with an h-index of 151. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.

What Scimago quartile is Acta Oncologica (Q1, Q2, Q3, or Q4)?

In the Scimago Journal Rank 2025 edition, Acta Oncologica is Q1 in 2 of its 4 subject categories and Q2 in the other 2. By category: Radiology, Nuclear Medicine and Imaging: Q1, #67 of 360; Medicine (miscellaneous): Q1, #562 of 2,517; Hematology: Q2, #43 of 151; Oncology: Q2, #154 of 426. Its best category quartile is Q1. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Acta Oncologica is cited about 2.7 times per paper over two years, with an h-index of 151.

What is the Web of Science (JCR) quartile of Acta Oncologica?

The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Acta Oncologica. The open equivalent is its best Scimago quartile, Q1 in Radiology, Nuclear Medicine and Imaging and 1 other category, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.

Is Acta Oncologica open access?

Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.

How long does Acta Oncologica take to publish a paper?

Submission to publication for Acta Oncologica takes about ~9 wk — DOAJ self-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Acta Oncologica.

Ready to submit? Tools for your next paper

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Similar venues

Compare it with its peers: Ranked Pulmonary and Respiratory Medicine journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.

Command palette

Jump anywhere, run any action.